Crossref
Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy
Journal of Urology and Renal Diseases · 2016
DOI: 10.29011/2575-7903.000109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Urology and Renal Diseases, 2016. Verfasst von Vishal V Ramteke und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ramteke, V. V., Dash, S. R., Bose, S., & Jain, R. (2016). Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy. Journal of Urology and Renal Diseases. https://doi.org/10.29011/2575-7903.000109
Vancouver
Ramteke VV, Dash SR, Bose S, Jain R. Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy. Journal of Urology and Renal Diseases. 2016. doi:10.29011/2575-7903.000109
BibTeX
@article{Ramteke2016,
author = {Ramteke, Vishal V and Dash, Sudhir Ranjan and Bose, Shubhadeep and Jain, Ritu},
title = {Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy},
journal = {Journal of Urology and Renal Diseases},
year = {2016},
doi = {10.29011/2575-7903.000109}
}
EUVIMED